Navigation Links
NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device

NESHER, Israel, April 21 /PRNewswire/ -- NanoVibronix, a medical device company specializing in applications that implement surface ultrasound waves, announced that its novel device has received CE approval in Europe for additional claims of wound healing. PainShield is the first hands-free, patch-based device that uses surface ultrasound waves for therapeutic treatment of wounds. The innovative PainShield consists of a disposable patch connected to a portable driver. PainShield for wound therapy will be introduced at the upcoming European Wound Management Association (EWMA) conference in Helsinki, Finland on May 20 - 22, 2009.

"My experience with PainShield has shown that it is one of the most striking therapeutic modalities in chronic wound care. PainShield implements the benefits of ultrasound to enhance the therapeutic processes required for chronic wound healing, and has shown to do that repeatedly both in the clinical and home setting. ", stated Dr. Jonathan Rosenblum, Director, Diabetic Foot Service, Shaare Zedek Medical Center, Jerusalem, Israel. Dr. Rosenblum will be presenting his experience with PainShield for chronic wounds at the International Conference of Dermatology (ICD), Prague, Czech Republic on May 20 - 24, 2009.

Dr. Leon Gilad, Chief of Wound Care at Hadassah University Medical Center, Jerusalem, Israel, said, "The beneficial properties of low frequency, low intensity ultrasound in a compact, convenient patch allows for a whole new dimension in wound therapy. The ability to place the PainShield patch on healthy skin adjacent to the wound allows the ongoing wound care to continue uninterrupted, while therapeutic ultrasound is provided simultaneously to the wound site. In addition to the wound healing benefits of the PainShield, we have seen a dramatic diminishing of wound pain when pain was present."

NanoVibronix CEO, Dr. Harold Jacob, added, "PainShield, which implements our unique low frequency ultrasound platform, has been shown in a number of independent studies to have powerful tissue regenerative properties. NanoVibronix has created a platform that allows physicians to easily apply therapeutic ultrasound to assist in wound healing without interfering with any of the other modalities that are being utilized. Our simple-to-use, portable patch-based device can treat wounds in the hospital or at home, allowing patients to continue with their daily activities."

About the Company

NanoVibronix, located in Nesher Israel, develops medical devices that implement its proprietary therapeutic ultrasound technology. The innovative portable PainShield device for treatment of pain gained FDA clearance in October 2008. The Company is planning to launch the product in the USA during the second half of 2009. The company has also developed a unique line of catheter-based disposable ultrasound devices designed to treat catheter associated injury including pain, discomfort and biofilm formation. The first two products in this family are the UroShield(TM) for indwelling urinary catheters and the NG-Shield(TM) for indwelling Nasogastric tubes.

    For more information, please contact:

    Amir Rippel, VP Marketing
    NanoVibronix Ltd.
    Tel: +972-4-820-0581
    Fax: +972-4-820-2794

SOURCE NanoVibronix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of ... 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session on ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
Breaking Medicine News(10 mins):